OBJECTIVE: To clarify the sequence of cytokines and inflammatory cells in enteroviral meningitis. METHODS: Cerebrospinal fluid (CSF) was collected from 86 patients who received a diagnosis of enteroviral meningitis after detection of the enteroviral genome in the CSF using polymerase chain reaction. Twenty-one of 86 patients had repeated lumbar punctures. Cytokine concentrations were measured acutely and in 32 samples collected during recovery. RESULTS: The proinflammatory cytokines (interleukin [IL]-6, IL-8, and interferon-gamma) were detected at significantly higher concentrations during the acute phase when enteroviral genomes were present. Proinflammatory cytokines decreased to normal levels in the recovery phase when enteroviral genomes disappeared. Anti-inflammatory concentrations (IL-10 and transforming growth factor-beta1) were significantly higher in the recovery phase than in the acute phase. Of the 86 CSF samples collected in the acute phase, 11 had no pleocytosis (<10 white blood cells/mm(3)). In 7 of those 11 CSF samples, IL-6 and IL-8 levels were as high as those in the 75 samples with pleocytosis (>or=10 white blood cells/mm(3)). Seven patients were considered to be in the initial stage of their illness when production of proinflammatory cytokines were high but leukocytes had not yet infiltrated the cerebrospinal cavity. CONCLUSIONS: The inflammatory process observed in human enteroviral meningitis is comparable with that observed in animal models: 1) infection induces proinflammatory cytokine production, followed by infiltration of white blood cells into the infected area, and 2) inflammation is terminated by the anti-inflammatory cytokines that are produced when pathogens are eliminated.
OBJECTIVE: To clarify the sequence of cytokines and inflammatory cells in enteroviral meningitis. METHODS: Cerebrospinal fluid (CSF) was collected from 86 patients who received a diagnosis of enteroviral meningitis after detection of the enteroviral genome in the CSF using polymerase chain reaction. Twenty-one of 86 patients had repeated lumbar punctures. Cytokine concentrations were measured acutely and in 32 samples collected during recovery. RESULTS: The proinflammatory cytokines (interleukin [IL]-6, IL-8, and interferon-gamma) were detected at significantly higher concentrations during the acute phase when enteroviral genomes were present. Proinflammatory cytokines decreased to normal levels in the recovery phase when enteroviral genomes disappeared. Anti-inflammatory concentrations (IL-10 and transforming growth factor-beta1) were significantly higher in the recovery phase than in the acute phase. Of the 86 CSF samples collected in the acute phase, 11 had no pleocytosis (<10 white blood cells/mm(3)). In 7 of those 11 CSF samples, IL-6 and IL-8 levels were as high as those in the 75 samples with pleocytosis (>or=10 white blood cells/mm(3)). Seven patients were considered to be in the initial stage of their illness when production of proinflammatory cytokines were high but leukocytes had not yet infiltrated the cerebrospinal cavity. CONCLUSIONS: The inflammatory process observed in humanenteroviral meningitis is comparable with that observed in animal models: 1) infection induces proinflammatory cytokine production, followed by infiltration of white blood cells into the infected area, and 2) inflammation is terminated by the anti-inflammatory cytokines that are produced when pathogens are eliminated.
Authors: Mark D Unger; Josef Pleticha; James E Collins; Anibal G Armien; Jennifer L Brazzell; Laura K Newman; Lukas F Heilmann; Jodi A Scholz; Timothy P Maus; Andreas S Beutler Journal: Mol Ther Date: 2017-08-01 Impact factor: 11.454
Authors: Raida El Hiar; Samir Haddad; Hela Jaïdane; Didier Hober; Manel Ben M'hadheb-Gharbi; Maria Gullberg; Mohamed Neji-Guediche; A Michael Lindberg; Jawhar Gharbi; Mahjoub Aouni Journal: Indian J Virol Date: 2012-09-04
Authors: Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius Journal: Drugs Date: 2013-02 Impact factor: 9.546
Authors: Stephanie C M de Crom; Marceline A M van Furth; Marcel F Peeters; John W A Rossen; Charles C Obihara Journal: Eur J Pediatr Date: 2011-11-22 Impact factor: 3.860